, March 16, 2012/PRNewswire-iReach/
, Inc. today announced that it has won a share of a U.S. Department of Defense $492-million
, four-year multiple award contract to provide a range of professional medical staff to Army, Air Force and Navy medical treatment facilities in Washington, D.C.
and at Joint Task Force capital medical facilities in the Northeast.
InGenesis will supply medical professionals to Walter Reed National Naval Medical Center, clinics in the Pentagon, Andrews and Bolling Air Force Bases and other sites. InGenesis will provide these facilities with physicians, nurses, behavioral health and dental professionals and ancillary staff. The contract was awarded to nine companies including InGenesis.
Veronica Edwards, President and CEO of InGenesis, said, "InGenesis is prepared to meet the critical direct healthcare provider needs of the Department of Defense's new flagship military treatment facilities â Walter Reed National Military Medical Center at Bethesda and Fort Belvoir Community Hospital. We are proud to service our military men and women at facilities in the national capital region. Being selected by the Department of Defense for this important procurement underscores the confidence they have in InGenesis based on our successful track record."
InGenesis, Inc. has provided high-quality staffing and global consulting solutions to clients in a diversity of industries since 1998. InGenesis specializes in servicing the healthcare and life sciences industries and excels at recruiting and managing medical and scientific personnel, including clinical researchers, subject matter experts, physicians, nurses, allied health and ancillary specialists. InGenesis has evolved to service commercial as well as military, federal and state government clients and is certified by the Small Business Administration as an 8(a) and Woman-Owned Small Business (WOSB).
Media Contact:Julie Buser of Ingenesis, Inc., 210-366-0033, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE InGenesis, Inc.